Predicting Response to Pregabalin from Pretreatment Pain Quality: Clinical Applications of the Pain Quality Assessment Scale
Arnold R. Gammaitoni(Merck & Co., Inc., Rahway, NJ, USA (United States)), David Hewitt(Glasgow Royal Infirmary), Mark P. Jensen(University of Washington), James A. Bolognese(Cytel (United States)), Bradley S. Galer(Rapt Therapeutics (United States)), Steven S. Smugar(Merck & Co., Inc., Rahway, NJ, USA (United States)), Achilles Alon(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 16
Related Papers
Advances in Neuropathic Pain
|Archives of Neurology|2003|1.2k
Sources of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation
|American Journal of Clinical Nutrition|1979|997
MALIGNANT DISEASE IN CHILDHOOD AND DIAGNOSTIC IRRADIATION IN UTERO
|The Lancet|1956|569
A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications
|British Journal of Anaesthesia|2018|432